You are here

Alpine Immune Sciences

What about the company Vertex didn’t buy?

Stat

Fri, 04/12/24 - 11:05 am

Vertex Pharmaceuticals

Alpine Immune Sciences

Vera Therapeutics

IgA nephropathy

Vertex to buy kidney disease drugmaker Alpine for $4.9B

BioPharma Dive

Wed, 04/10/24 - 06:05 pm

Vertex Pharmaceuticals

Alpine Immune Sciences

IgA nephropathy

Hope springs for April inhibition

EP Vantage

Tue, 06/13/23 - 10:27 am

Chinook Therapeutics

April inhibition

Vera Therapeutics

Alpine Immune Sciences

Akso Biopharmaceutical

Aurinia Pharmaceuticals

Second Patient Death Shutters Alpine's Immuno-Oncology Program

BioSpace

Mon, 10/24/22 - 12:28 pm

Alpine Immune Sciences

clinical trials

Death in Alpine's Keytruda combo trial triggers clinical hold, raises specter of earlier tragedy

Fierce Biotech

Mon, 03/7/22 - 11:01 pm

Alpine Immune Sciences

clinical trials

Alpine and Merck Study Checkpoint, Anti-PD-1 Cancer Combo in Collab Study

BioSpace

Wed, 06/30/21 - 09:58 pm

Alpine Immune Sciences

Forget Biogen: These 2 Under-the-Radar Biotechs Are Also Celebrating Breakthroughs

Motley Fool

Sun, 06/13/21 - 10:44 pm

Alpine Immune Sciences

ASCO 2021 movers – PDS wins, but big pharma reigns

EP Vantage

Wed, 06/9/21 - 11:00 am

PDS Biotechnology

Spectrum Pharma

Black Diamond Therapeutics

Alpine Immune Sciences

Harpoon Therapeutics

AbbVie beefs up the immunology pipeline, betting up to $865M on a PhII-ready drug — and fueling a biotech stock frenzy

Endpoints

Thu, 06/18/20 - 10:55 am

Alpine Immune Sciences

Former Dendreon CEO debuts new public company in reverse merger

BioPharma Dive

Wed, 04/19/17 - 04:19 pm

Alpine Immune Sciences

Former Dendreon CEO Secures $48M for Cancer Immunotherapy Startup

Forbes

Mon, 06/13/16 - 10:36 am

cancer immunotherapy

Alpine Immune Sciences